(NASDAQ: CLGN) Collplant Biotechnologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.9%.
Collplant Biotechnologies's earnings in 2025 is -$13,003,000.On average, 1 Wall Street analyst forecast CLGN's earnings for 2025 to be -$1,030,906, with the lowest CLGN earnings forecast at -$1,030,906, and the highest CLGN earnings forecast at -$1,030,906. On average, 1 Wall Street analyst forecast CLGN's earnings for 2026 to be -$1,030,906, with the lowest CLGN earnings forecast at -$1,030,906, and the highest CLGN earnings forecast at -$1,030,906.
In 2028, CLGN is forecast to generate $5,841,801 in earnings, with the lowest earnings forecast at $5,841,801 and the highest earnings forecast at $5,841,801.